Saturday 17 October 2026
Export CON’s income statement to Excel — free account
Concentra Group Holdings Parent, Inc.
CON Healthcare Medical Care Facilities
Concentra Group Holdings Parent, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, up 13.9% from fiscal 2024. In the quarter to June 2026, revenue grew 10.0%, EPS grew 45.7%, free cash flow grew 91.6% and total debt fell 5.54%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
38.54
0.61
−1.56%
Follow CON
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|
P/E ratio |
11.17 | 11.17 | 11.17 | 13.10 | 15.14 |
Piotroski F-Score |
— | — | — | 4 | 6 |
Altman Z-Score |
— | — | — | 1.83 | 1.85 |
P/S ratio |
1.24 | 1.24 | 1.24 | 1.19 | 1.17 |
Altman Z″-Score (non-manufacturers) |
— | 2.27 | 2.88 | 1.30 | 1.23 |
P/FCF ratio |
13.13 | 13.13 | 13.13 | 10.74 | 12.76 |
Beneish M-Score |
— | — | (2.46) | (3.06) | (2.49) |
P/Operating CF |
33.22 | 33.22 | 33.22 | 24.10 | 21.27 |
Dividend Safety Score |
— | — | — | — | 62 |
P/B ratio |
1.87 | 1.87 | 1.87 | 8.05 | 6.30 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.44 | 1.44 | 1.44 | 1.87 | 1.86 |
EV/EBITDA |
7.21 | 7.21 | 7.21 | 9.51 | 9.71 |
EV/Operating CF |
10.88 | 10.88 | 10.88 | 12.94 | 14.39 |
EV/FCF |
15.24 | 15.24 | 15.24 | 16.90 | 20.32 |
Quick Ratio |
— | 0.87 | 0.90 | 1.31 | 1.00 |
Current Ratio |
— | 1.02 | 1.07 | 1.42 | 1.14 |
Net Debt/EBITDA |
0.00 | 1.80 | 1.23 | 3.47 | 3.61 |
Debt/Assets |
0.00% | 27.67% | 20.34% | 58.66% | 55.08% |
Debt/Equity |
0.00 | 0.65 | 0.41 | 5.27 | 3.93 |
Asset Turnover |
0.00 | 1.50 | 0.79 | 0.78 | 0.80 |
Operating CF/Net income |
1.39 | 1.65 | 1.30 | 1.65 | 1.68 |
Capex/Depreciation |
(0.51) | (0.62) | (0.89) | (0.93) | (1.02) |
Interest Coverage |
9.58 | 8.17 | 6.47 | 4.37 | 3.06 |
| 0.00% | 0.00% | 16.82% | 23.10% | 48.82% | |
| 0.00% | 14.52% | 7.77% | 6.86% | 6.19% | |
ROIC |
0.00% | 10.24% | 11.21% | 12.08% | 11.01% |
Return on Tangible Assets |
0.00% | 101.74% | 90.81% | 50.78% | 61.37% |
Average Days of Receivables |
0.00 | 43.66 | 42.93 | 41.82 | 43.51 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
9.11% | 8.70% | 8.27% | 8.23% | 9.40% |
Intangible Assets out of Total Assets |
0.00 | 0.58 | 0.62 | 0.57 | 0.60 |
Share Based Compensation of Revenue |
0.12% | 0.12% | 0.04% | 0.12% | 0.48% |
Graham Net Nets |
(0.34) | (0.34) | (0.34) | (0.80) | (0.82) |
Graham Number |
0.00 | 0.00 | 0.00 | 9.14 | 9.56 |
Earnings Yield |
8.95% | 8.95% | 8.95% | 7.63% | 6.61% |
Free Cash Flow Yield |
7.62% | 7.62% | 7.62% | 9.31% | 7.84% |
Revenue per Share |
16.47 | 16.55 | 17.64 | 16.64 | 16.86 |
Operating CF per Share |
2.76 | 2.63 | 2.25 | 2.41 | 2.18 |
Capex per Share |
(0.40) | (0.44) | (0.62) | (0.56) | (0.64) |
Free Cash Flow per Share |
2.37 | 2.19 | 1.63 | 1.84 | 1.54 |
Cash per Share |
0.00 | 0.36 | 0.30 | 1.60 | 0.62 |
Shareholders Equity per Share |
0.00 | 9.40 | 11.14 | 2.46 | 3.13 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 9.40 | 11.14 | 2.46 | 3.13 |
Free Cash Flow |
248.94 | 228.39 | 169.39 | 210.38 | 197.84 |
Working Capital |
— | 5.00 | 19.78 | 130.02 | 45.85 |
Capital Expenditures |
(41.70) | (45.94) | (64.92) | (64.30) | (81.56) |
Net Current Asset Value |
0.00 | (1,033.26) | (878.18) | (1,803.25) | (2,074.26) |
EV/EBIT |
8.43 | 8.43 | 8.43 | 11.66 | 12.03 |
Capex to Sales |
0.02 | 0.03 | 0.04 | 0.03 | 0.04 |
Price to Operating Income |
7.26 | 7.26 | 7.26 | 7.41 | 7.56 |
| Other line items | |||||
Depreciation/Fixed assets |
0.00 | 0.46 | 0.41 | 0.35 | 0.35 |
Cash ROIC |
0.00% | 13.82% | 10.16% | 10.83% | 9.63% |
Accounts Receivable Turnover |
0.00 | 0.00 | 8.70 | 8.76 | 9.10 |
Accounts Payable Turnover |
0.00 | 0.00 | 55.14 | 68.33 | 76.08 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 8.13 | 5.62 | 5.25 | 4.95 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | 211.23 | 216.96 | 237.81 |
Average Payables |
— | — | 24.04 | 20.08 | 20.38 |
Average Assets |
— | 1,148.62 | 2,315.40 | 2,427.36 | 2,689.78 |
Average Common Equity |
— | — | 1,070.15 | 720.84 | 340.87 |
Columns are period end dates